Conference Coverage - Conference Coverage - 148 · conference-coverage

ACC 21 Highlights

We discuss several of the important data coming out the American Heart Association 2020 meeting.

Thanks for listening. Please like, subscribe and give us a rating.

We discuss several of the important data coming out the European Society of Cardiology 2020 meeting.

Thanks for listening. Please like, subscribe and give us a rating.

We review and discuss a lot of exciting data and late-breaking results from the American College of Cardiology Scientific Sessions in March, 2020. Listen, Like, Subscribe, and give us a high rating!

Big trials presented at AHA 2019!! We have two interviews and we discuss ISCHEMIA, ISCHEMIA CKD, COLCOT, ORION-10, BETonMACE, AVR in asymptomatic very severe AS, GALILEO, DAPA-HF, and the Apple Heart study.

Listen, Like, Subscribe and don't forget to give us a Rating!!

The European Society of Cardiology is one of the largest annual cardiology meetings. Here we summarize all the important trials that were presented at this meeting and discuss their impact on clinical practice. Listen, Like, Subscribe and don't forget to give us a Rating!!

Editorial board members from JACC: Case Reports, JACC: Cardiovascular Imaging, and JACC: Cardiovascular Interventions host a joint Virtual Journal Club discussing research on valvular heart disease and structural interventions. JACC: Case Reports Editor-in-Chief Julia Grapsa, MD, Ph.D., FACC, moderates the event, and panelists include William A. Zoghbi, MD, MACC; Nicolo Piazza, MD, Ph.D., FACC; Nadeen N. Faza, MD, FACC; Edgar Argulian, MD; Maurizio Taramasso, MD, Ph.D.; and Rafael Vidal Pérez, MD, Ph.D.

Hani Najm, MD, FACC, Chair of the ACC Assembly of International Governors, shares why he believes providing opportunities for young physicians around the world to come to the United States for exposure to cardiovascular clinicians is one way to achieve the ACC’s Campaign for the Future’s goal to improve heart health around the world. Dr. Najm is proud to sponsor the Hani Najm Global Scholar Awards, which will allow two early career cardiologists from the Middle East and North Africa to come to the U.S. for an observership at a major health system and attend that year’s Annual Scientific Session. According to Dr. Najm, “Sharing knowledge is the best way to combat the increasing prevalence of cardiovascular disease around the world.” Get involved in ACC’s Campaign for the Future at https://www.ACC.org/Future

#ACCFuture #ACCIntl #TheFaceofCardiology

Listen to Expert Faculty discuss how to incorporate the use of GLP-1 RA and SGLT2 inhibitors into your healthcare setting in a multidisciplinary way. This discussion focuses on how to identify the key team members, how to communicate effectively across the care team, and how important education is on the successful collaboration across the care team continuum.

Listen to Expert Faculty discuss the paradigm shift for cardiologists in understanding how to use SGLT2i's and GLP-1RA's safely and effectively in their practice. This discussion focuses on when and how to safely commence these drugs, as well as when and how to engage other members of the care team.

Listen to Expert Faculty discuss the fundamental science and the mechanism to evidence around new antihyperglycemic drugs, and why exactly this is such an important topic. This conversation focuses on the key principles of adding GLP-1 RAs and SGLT2 inhibitors, and how using these drugs has been shown to have an important effect on reducing cardiovascular outcomes.

Drs. Peter Block, Deepak Bhatt, and Kim Eagle look back on Day 5 of AHA 2020 late-breaking science and featured clinical research, including results from the INVESTED trial (0:30). Visit https://www.acc.org/aha2020 for full meeting coverage.